Ramirez De Molina A - Search Results

1

Generation and characterization of monoclonal antibodies against choline kinase alpha and their potential use as diagnostic tools in cancer.

Gallego-Ortega D, Ramirez De Molina A, Gutierrez R, Ramos MA, Sarmentero J, Cejas P, Nistal M, González Barón M, Lacal JC. Gallego-Ortega D, et al. Among authors: ramirez de molina a. Int J Oncol. 2006 Aug;29(2):335-40. Int J Oncol. 2006. PMID: 16820874 Free article.

2

Targeting new anticancer drugs within signalling pathways regulated by the Ras GTPase superfamily (Review).

Ramírez De Molina A, Rodríguez-González A, Lacal JC. Ramírez De Molina A, et al. Int J Oncol. 2001 Jul;19(1):5-17. Int J Oncol. 2001. PMID: 11408916 Review.

3

Inhibition of ChoK is an efficient antitumor strategy for Harvey-, Kirsten-, and N-ras-transformed cells.

Ramírez de Molina A, Rodríguez-González A, Penalva V, Lucas L, Lacal JC. Ramírez de Molina A, et al. Biochem Biophys Res Commun. 2001 Jul 27;285(4):873-9. doi: 10.1006/bbrc.2001.5250. Biochem Biophys Res Commun. 2001. PMID: 11467831

4

Regulation of choline kinase activity by Ras proteins involves Ral-GDS and PI3K.

Ramírez de Molina A, Penalva V, Lucas L, Lacal JC. Ramírez de Molina A, et al. Oncogene. 2002 Jan 31;21(6):937-46. doi: 10.1038/sj.onc.1205144. Oncogene. 2002. PMID: 11840339

5

Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy.

Ramírez de Molina A, Gutiérrez R, Ramos MA, Silva JM, Silva J, Bonilla F, Sánchez JJ, Lacal JC. Ramírez de Molina A, et al. Oncogene. 2002 Jun 20;21(27):4317-22. doi: 10.1038/sj.onc.1205556. Oncogene. 2002. PMID: 12082619

6

Modulation of phospholipase D by Ras proteins mediated by its effectors Ral-GDS, PI3K and Raf-1.

Lucas L, Penalva V, Ramírez de Molina A, Del Peso L, Lacal JC. Lucas L, et al. Among authors: ramirez de molina a. Int J Oncol. 2002 Sep;21(3):477-85. Int J Oncol. 2002. PMID: 12168089

7

Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers.

Ramírez de Molina A, Rodríguez-González A, Gutiérrez R, Martínez-Piñeiro L, Sánchez J, Bonilla F, Rosell R, Lacal J. Ramírez de Molina A, et al. Biochem Biophys Res Commun. 2002 Aug 23;296(3):580-3. doi: 10.1016/s0006-291x(02)00920-8. Biochem Biophys Res Commun. 2002. PMID: 12176020

8

Phospholipase D and choline kinase: their role in cancer development and their potential as drug targets.

Rodríguez-González A, Ramírez de Molina A, Benítez-Rajal J, Lacal JC. Rodríguez-González A, et al. Among authors: ramirez de molina a. Prog Cell Cycle Res. 2003;5:191-201. Prog Cell Cycle Res. 2003. PMID: 14593713 Review.

9

Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells.

Rodríguez-González A, Ramírez de Molina A, Fernández F, Ramos MA, del Carmen Núñez M, Campos J, Lacal JC. Rodríguez-González A, et al. Among authors: ramirez de molina a. Oncogene. 2003 Dec 4;22(55):8803-12. doi: 10.1038/sj.onc.1207062. Oncogene. 2003. PMID: 14654777

10

From Ras signalling to ChoK inhibitors: a further advance in anticancer drug design.

Ramírez de Molina A, Rodríguez-González A, Lacal JC. Ramírez de Molina A, et al. Cancer Lett. 2004 Apr 8;206(2):137-48. doi: 10.1016/j.canlet.2003.08.031. Cancer Lett. 2004. PMID: 15013519 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters